Sigma-Aldrich — Investor Day (March 2007)
124 slides from Sigma-Aldrich's investor day presentation, Mar 14, 2007

Slide 1: Sigma-Aldrich Corporation
Sigma-Aldrich Corporation We are Committed to Accelerating our Customers’ Success through Leadership in Life Science, High Technology and Service Exhibit 99.1

Slide 2: Cautionary Statements
sigma-aldrich.com Cautionary Statements Our presentation today will include forward looking statements about the Company’s future performance, goals, strategic actions and initiatives and similar intentions and beliefs, including expectations for sales and earnings growth, cash flow, debt levels, sh

Slide 3: Committed to Accelerating our Customers' Success
We are Committed to Accelerating our Customers’ Success through Leadership in Life Science, High Technology and Service Enabling Science Globally Through Innovation

Slide 4: A Major Supplier In Life Science & High Technology
sigma-aldrich.com A Major Supplier In Life Science & High Technology Sigma-Aldrich Overview 2006 Performance - $1.8 Billion in Sales - 21.1% Pretax Margin - 20.9% Return on Equity - Strong Cash Flow 130,000 Products 1,000,000 Customers 70,000 Accounts 7,500 Employees in 36 Countries

Slide 5: Five Key Initiatives To Achieve Objectives
sigma-aldrich.com Five Key Initiatives To Achieve Objectives Increase Focus on Becoming Customer Centric Maintain Leadership in Life Science & High Technology Strategic Plan Objectives Building For The Future Strategic Financial Achieve Minimum 10% Annual Top & Bottom Line Growth Maintain 20% Return

Slide 6: Five Key Initiatives Set Actions For 2006
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 7: Achieve Above Market Growth
sigma-aldrich.com Achieve Above Market Growth Research Essentials 20% 4% Research Specialties Research Biotech >10 SAFC >10 Internal Acquisitions Total Sales Growth Goals Sales Sales Growth Building For The Future

Slide 8: Three Horizon Vision To Achieve Short & Long-Term Objectives
sigma-aldrich.com Three Horizon Vision To Achieve Short & Long -Term Objectives Research Essentials Research Specialties Research Biotech SAFC Licensing Technology Equity Investments Small Acquisitions REVITALIZE INCUBATE FOCUS & INVEST Building For The Future

Slide 9: Sigma-Aldrich Largest Research Chemical Supplier
sigma-aldrich.com Sigma-Aldrich Largest Research Chemical Supplier Research Market $8.75 Billion Worldwide 3-4% Growth USA 40%; Europe 30%; Int’l 30% Our Markets Significant Changes: • Fisher Combined With Thermo-Electron • Biotech Competitors Transitioning 0.5 1.5 VWR Qiagen Becton Dickinson Wako T

Slide 10: SAFC - Top Player
sigma-aldrich.com SAFC - Top 10 Player Fine Chemical Market $50 Billion Worldwide 2-3% Growth USA 55%; Europe 30%; Int’l 15% Our Markets Significant Changes: • Lonza/Cambrex merger creates a tie for #4 • NPIL and Dishman (Indian Companies) new to list • Clariant dropped, (pharma spin-off) – Replaced

Slide 11: Compound Annual Growth - Sales Growth
sigma-aldrich.com 10% Compound Annual Growth - Last 5 Years Sales Growth Adjusted for Currency/Acquisitions Reported Acquisition Benefit Financial Performance 8.3% 6.9% 7.6% 0.3% 8.6% 3.3% 18.3% 17.6% 7.9% 7.5% 0% 5% 10% 15% 20%

Slide 12: Research Chemicals Sales Growth Exceeds Market Growth Rate
sigma-aldrich.com Sales Growth Exceeds Market Growth Rate 0% 2% 4% 6% 8% 10% 12% 14% 16% Financial Performance Research Chemicals (72% -A) – Sales Growth Reported Adjusted for Currency Market

Slide 13: Market Conditions Have Improved
sigma-aldrich.com Market Conditions Have Improved Financial Performance Fine Chemicals (28% -A) – Sales Growth -10% 0% 10% 20% 30% 40% 50% 60% 70% Reported Adjusted for Currency / Acquisitions Acquisitions Market

Slide 14: Profit (EPS) Growth
sigma-aldrich.com Year Compound Annual Growth of 15% Profit (EPS) Growth Reported Operations Stock Buyback Currency Adjusted Financial Performance 9% 9% 6% 3% 25% 10% 13% 8% 9% 9% 0% 5% 10% 15% 20% 25% 30%

Slide 15: EPS Contributors - 2006 vs. 2005
sigma-aldrich.com $0.00 $0.50 $1.00 $1.50 $2.00 $2.50 (4%) $0.19 $1.88 $0.04 10% $0.08 4% $2.05 ($0.08) 0% $0.00 2% ($0.01) (1%) EPS Contributors - 2006 vs. 2005 (A) ($0.08) (4%) (A) EPS data has been adjusted for the effect of the 100% stock dividend. (B) tax rate includes the favorable effect of a

Slide 16: Return on Equity
sigma-aldrich.com 20% Target 19.5% 20.4% 21.1% 21.1% 20.9% 0% 5% 10% 15% 20% 25% Return on Equity Financial Performance

Slide 17: Accelerate Customers' Success
sigma-aldrich.com Accelerate Customers' Success 2006 Highlights Official Recognition By Three Top Life Science Companies Letters Of Commendation From Customers About Our Employees Increased Revenue Growth From Managed Global Accounts (>14%) Customer-Centric Culture

Slide 18: 25% Of Sales In CAPLA Markets By 2010
sigma-aldrich.com 25% Of Sales In CAPLA Markets By 2010 2006 Highlights Sales Growth In CAPLA: 14% Acquisition Of Beijing Superior & Expansion of Warehouse And Service Expand In Faster Growing Geographic Markets Sigma-Aldrich China Staff Bangalore Completion Of Campus In Bangalore, India China Offic

Slide 19: E-Centric Organization
sigma-aldrich.com E-Centric Organization 2006 Highlights Key Drivers – Migration From Print To Electronic Media Improved Search Capabilities And Technical Content Integrated With Affiliated Websites (Google, etc.) Launched $7.0 Million Project To Replace Current E-Commerce Platform Building On Inter

Slide 20: Process Improvement Exceeded Savings Target
sigma-aldrich.com Far Exceeded $15.0 Million Savings Target While Improving Quality & Service 2006 Highlights Involving Customers In Improvement Initiatives Product Quality Improvements Initiated Supply Chain Optimization Review Leverage Process Improvement For Excellent Investment Returns

Slide 21: Added New Capabilities
sigma-aldrich.com Added New Capabilities 2006 Highlights Acquisitions Beijing Superior - China Arklow Plant - Ireland Pharmorphix - U.K. Advanced Separation Technologies - USA Completed 110 New Technology & Product In Licensing Deals Revenue Stream From Outlicensing Deals $1.5 Million Arklow Pharmor

Slide 22: Breadth Of Initiatives Offsets Market Conditions
sigma-aldrich.com Breadth Of Initiatives Offsets Market Conditions 2006 Challenges Big Pharma Focused On Driving Drug Candidates To Market Less Than Robust Growth in U.S. Academic Accounts Growing Complexity In Intellectual Property Continued Weakness In Japanese Research Spending Slower Adoption Ra

Slide 23: Stock Price Doubled Over Last 5+ Years
sigma-aldrich.com Price Doubled Over Last 5+ Years $5 $10 $15 $20 $25 $30 $35 $40 $45 Low 31 High 29 Period End Price High 40 Low 21 High 31 Low 27 High 34 Low 28 High 43 Low 37 Low 19 High 27 Stock Price (*) (*) Post-Split (To 2-28)

Slide 24: Investment Grade Debt Ratings
sigma-aldrich.com Investment Grade Debt Ratings It’s All About Exceeding Expectations

Slide 25: Favorable Performance vs. Markets
sigma-aldrich.com Favorable Performance vs. Markets Indices – Stock Price % Returns 5-Years 3-Years 1-Year Dow Jones S&P 500 NASDAQ Sigma-Aldrich Last Last Last

Slide 26: Summary of 2006 Performance
sigma-aldrich.com New Initiatives Needed To Boost Sales Growth Summary of 2006 Performance Successfully Launched New Initiatives Improved Pre-Tax Margins Achieved Geographic Expansion & Internet Goals Exceeded Process Improvement Objectives Added Technology, Capacity & Geographic Reach Through Four

Slide 27: 2007 Projections
sigma-aldrich.com Exceed Market Growth / Hold Pre-Tax Margins 2007 Projections Key Assumptions December 2006 FX Rates Effective Tax Rate Of 30-31% Repurchase Of Up To 4 Million Shares Sales (excluding future acquisitions) Organic % Currency % Acquisition % EPS ($2.15 - 2.25) % Return On Equity > 20

Slide 28: Stay Focused, While Remaining Flexible
sigma-aldrich.com Stay Focused, While Remaining Flexible Building For The Future Aggressively Execute Existing Strategic Plan Exploit Opportunities In Fine Chemicals And Faster Growing Economies Expand E-Commerce & Internet Capabilities Optimize Supply Chain Efficiency

Slide 29: Recent Additions & Promotions Strengthen Management Team
sigma-aldrich.com Recent Additions & Promotions Strengthen Management Team Organization Jai Nagarkatti President & CEO Doug Rau Vice President Human Resources Steve Walton Vice President EHS & Quality Frank Wicks President SAFC Dave Julien President Research Specialties Operations Gilles Cottier Pre

Slide 30: Committed to Accelerating our Customers' Success
We are Committed to Accelerating our Customers’ Success through Leadership in Life Science, High Technology and Service Enabling Science Globally Through Innovation

Slide 31: Five Key Initiatives
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 32: Research Essentials: Innovative Solutions For Economic Buyers
sigma-aldrich.com Research Specialties 37% ($670M) Research Essentials 20% ($355M) SAFC 28% ($496M) Research Biotech 15% ($277M) Innovative Solutions For Economic Buyers Research Essentials Business Units Customer Types Driving Forces Growth Goal Research Essentials Economic Buyers Relationship Sell

Slide 33: Changing Distribution Landscape
sigma-aldrich.com Changing Distribution Landscape Research Essentials Market Overview Market - Growth – 1 to 2% - Size - >$2.0 Billion Customer Requirements - Low Transactional Costs - Customized Service, Packaging, And Pricing - Responsive And Flexible Account Management - Support Outsourcing Partn

Slide 34: Relationship Selling
sigma-aldrich.com Relationship Selling Research Essentials Value Drivers Account Management - E-Commerce Solutions - Total Cost Of Ownership - Supply Chain Solutions Product Portfolio - Value Pricing - Consistent Quality - Customization

Slide 35: Plan Globally - Service Locally
sigma-aldrich.com Plan Globally - Service Locally Research Essentials Value Drivers International Markets - Conduct Business In Local Languages - Support Customer Shift To Where Work Gets Done - Supply Chain Enhancement

Slide 36: Focus On Global Innovation
sigma-aldrich.com Focus On Global Innovation Research Essentials Strategy Align Resources To Meet Largest Customers’ Changing Needs Create Innovative Solutions & Value For Economic Buyer Leverage Our Global Presence And Common Systems Maximize Components Of Our Pricing Strategy Continue To Build Inf

Slide 37: Take Market Share For Growth
sigma-aldrich.com Take Market Share For Growth Global Account Management - Differentiate Products/Services Through Customized Solutions - Increase and Retain Access To Researchers In Key Accounts - Improve Customer Segmentation For Sales Effectiveness Product Portfolio - Maximize Pricing Strategy -

Slide 38: Take Market Share For Growth
sigma-aldrich.com Take Market Share For Growth Leverage Global Presence - Enhance Service And Infrastructure In High Growth Economies With Aggressive Focus In China & India - Increase Use Of Selected International Locations To Support Our Overall Global Business Strategy - Upgrade Organization With

Slide 39: Take Market Share For Growth - Supply Chain
sigma-aldrich.com Take Market Share For Growth Research Essentials Growth Opportunities And Tactics Supply Chain Opportunities - Find Low Cost Manufacturing Solutions - Secure Additional OEM Supply Agreements In High Growth Asian Economies - Use Supply Chain Expertise To Meet Customers Needs

Slide 40: Leverage Strong Leadership Position
sigma-aldrich.com Leverage Strong Leadership Position Research Essentials Distinct Advantages Over Competitors Strong Global Brand Recognition Demonstrated Service Culture Trusted Business Partner Global Presence Common Systems Broad Product Offering Supply Chain Expertise

Slide 41: Delivered Targeted Growth
sigma-aldrich.com Delivered Targeted Growth Research Essentials 2006 Results 2006 Results: 3.8% Sales Growth (Currency Adjusted) Key Drivers - Global Account Management Double Digit Growth At 25 Largest Accounts Official Recognition By 3 Large Life Science Companies - Product Portfolio Value Pricing

Slide 42: Take Market Share & Leverage Global Reach
sigma-aldrich.com Take Market Share & Leverage Global Reach Research Essentials 2007 Goals And Initiatives Global Account Management – Goal 7+% - Expand On New And Innovative Solutions - Focus On Largest Customers Product Portfolio – Goal 4% - Expand On Best Practices - Drive OEM Supply Agreements I

Slide 43: Research Specialties: Innovative Solutions In Services & Products
sigma-aldrich.com Research Specialties 37% ($670M) Research Essentials 20% ($355M) SAFC 28% ($496M) Research Biotech 15% ($277M) Innovative Solutions In Services & Products Research Specialties Business Units Customer Types Driving Forces Growth Goal Research Essentials Economic Buyers Relationship

Slide 44: We Are The Leader
sigma-aldrich.com We Are The Leader Research Specialties Market Overview Market - Growth – 2 to 3% - Size - >$2.5 Billion Customer Requirements - Easy To Locate Products - Simple And Transparent Order Processes - Product Availability And Rapid Delivery Competitors - A Few Large Competitors - Numerou

Slide 45: The Leader In Customer & Technical Services
sigma-aldrich.com The Leader In Customer & Technical Services Research Specialties Value Drivers Product Portfolio - Breadth Of Line - ~100,000 Products - Specialty, Unique And Common Products - Innovative, New Products ~3,000 Per Year - Competitively Priced - Consistent Quality And Availability Int

Slide 46: Revitalize Our Core Business
sigma-aldrich.com Revitalize Our Core Business Research Specialties Strategy Maintain #1 Market Position Enhance World-Class Internet Capabilities Site Target Marketing Across Regions And Products Provide Innovative New Products And Differentiate Services Provide Low Cost, High Quality Products in S

Slide 47: Broadest Product Line Available
sigma-aldrich.com Broadest Product Line Available Research Specialties Growth Opportunities And Tactics Product Portfolio - Implement Pricing Strategies - Enhance Business Development Function - Increase Collaboration, Licensing, And Exclusive Relationships - Innovative New Products - Provide Innova

Slide 48: Recognized As #1 Catalogs In Market
sigma-aldrich.com Recognized As #1 Catalogs In Market Research Specialties Growth Opportunities And Tactics Our Firepower: Print Global Coverage 1 M catalogs/year 3 M newsletters, 30 issues/year Hitting the Target 1.6 M names, up to date, incl profiles Directed to specified “communities” Being Effec

Slide 49: The Catalog Of The Future
sigma-aldrich.com The Catalog Of The Future Our Shopping Mall: The Web Number 1 Site in Research Industry: 18 M Visits In 2006 Extraordinary Search Capabilities 660K Registered Web Users 5 M E-Mails Search Engine Marketing Sponsored Ads, Collaboration Merchandising E-Commerce: $450 M Sales Research

Slide 50: Extend Our Offering Of Products And Services
sigma-aldrich.com Extend Our Offering Of Products And Services New Products New “Solutions” And Services New Platforms - MIP (Molecular Imprinted Polymers) - Certified Standards - Fused Core Particles - Fluorescent Nanoparticles - Chiral Separation Acquisitions (IP/Companies) st year sales of new pr

Slide 51: Strengthen Our Leadership Position
sigma-aldrich.com Strengthen Our Leadership Position Research Specialties Distinct Advantages Over Competitors Customer Communication - 1 Million Mail List Names - 660K Web Registration Internet, Catalog And Newsletter - 18M Internet Visits - 1M New Catalogs/Annually - 3M Newsletters/Annually Global

Slide 52: Sales Initiatives Working
sigma-aldrich.com Sales Initatives Working Research Specialties 2006 Results 2006 Results: 6.5% Sales Growth (Currency Adjusted) Key Drivers - New Services And Products - International Expansion - Price - Internet - Global Agreements/Relationships - Targeted Marketing

Slide 53: Continue The Revitalization Of Core Business
sigma-aldrich.com Continue The Revitalization Of Core Business Research Specialties 2007 Goals And Initiatives Products - Expand Attractive Groups; Selectively Add Resources Customer Communication - Refine Segment Ownership - Sales Development In Asia/Pacific (SAMS, Web, Print, Local Adaptions) - Dr

Slide 54: Research Biotech: Innovative Life Science Products
sigma-aldrich.com Research Specialties 37% ($670M) Research Essentials 20% ($355M) SAFC 28% ($496M) Research Biotech 15% ($277M) Innovative Life Science Products Research Biotech Business Units Customer Types Driving Forces Growth Goal Research Essentials Economic Buyers Relationship Selling 4% Rese

Slide 55: Continued Investment In Technology
sigma-aldrich.com Continued Investment In Technology Research Biotech Market Overview Market - Growth - 4-5% - Size – >$4.0 Billion Customer Requirements - Technology And Solution-Oriented Products - Technical Sales And Support Competitors - Invitrogen, Qiagen, GE Healthcare - Recognized Technology

Slide 56: Providing Innovative Solutions
sigma-aldrich.com Providing Innovative Solutions Research Biotech Value Drivers Product Portfolio - Enabling - Validation Data - Timesaving And Convenience Sales, Marketing and Business Development - “White Coat” Selling With A Technical Sales Force - Applications Marketing On The Web - IP Based Col

Slide 57: Lead With Break Through Products
sigma-aldrich.com Lead With Break Through Products Research Biotech Strategy Focus On the Drug Discovery Workflow Target Market Sub-Segments Growing At > 10% First To Market With Innovative, Solution Oriented Products Acquire, License And Develop New Technologies Continue Integration Into The Scient

Slide 58: Focus On The Drug Discovery Workflow
sigma-aldrich.com Focus On The Drug Discovery Workflow Research Biotech Growth Opportunities & Tactics Nucleic Acid Purification Extraction Purification Analysis PCR Primer design Standard PCR RT-PCR Sequencing Reaction Separation Detection Assemblage Library Construction Restriction digestion Gene

Slide 59: Target Market Sub-Segments Growing At 10+%
sigma-aldrich.com Target Market Sub-Segments Growing At 10+% Best in Class Portfolio Amplification RNAi RNA labeling Primers RNA Isolation QPCR RNA profiling Top 20 depletor AQUA Protein & AB arrays Peptides & AS Lectins Rec Proteins Mass Spec Rgnts WGA Custom DNA NAP NAA (PCR) C&E Sample Prep Antib

Slide 60: Broad Opportunities In Biotechnology
sigma-aldrich.com Broad Opportunities In Biotechnology Research Biotech Growth Opportunities And Tactics Emerging Market Sub-Segments (Genomics/Proteomics) Large Pharma And Biotech Projects Custom Collaborations Recent Acquisitions And Licensed Technologies IP Out-licensing Revitalize Sales to Acade

Slide 61: Broadest Capabilities In Gene To Drug Spectrum
sigma-aldrich.com Broadest Capabilities In Gene To Drug Spectrum Research Biotech Distinct Advantages Over Competitors Broad Access To Customers/Collaborators In Depth Expertise Across The Research Workflow Widest IP Portfolio In Gene Silencing Leading Position In Custom Genomics

Slide 62: Accelerate Investment To Improve Growth
sigma-aldrich.com Accelerate Investment To Improve Growth Research Biotech 2006 Results 2006 Results: 5.6% Sales Growth (Currency Adjusted) Key Drivers - Double Digit Growth In Genomics And Global Accounts - Slow Growth In Oligos And Academic Accounts - New Technologies Getting Traction, But Slower

Slide 63: Increase Technical Selling And Product Focus
sigma-aldrich.com Increase Technical Selling And Product Focus Research Biotech 2007 Goals And Initiatives Hightened Focus On Pharma/Biotech Major Growth Opportunities With Gene Silencing Products Key New Product Launches In Genomics/Proteomics Maximizing Use Of Web Based Promotional Tools Unleash S

Slide 64: SAFC: Innovative Solutions For Manufacturing Customers
sigma-aldrich.com Research Specialties 37% ($670M) Research Essentials 20% ($355M) SAFC 28% ($496M) Research Biotech 15% ($277M) Innovative Solutions For Manufacturing Customers SAFC Business Units Customer Types Driving Forces Growth Goal Research Essentials Economic Buyers Relationship Selling 4%

Slide 65: Large Supplier In Fragmented Market
sigma-aldrich.com Large Supplier In Fragmented Market Market - Size – $50 Billion - Growth – 2 – 3 % Customer Requirements - Semi–Bulk: Quality, Price And Availability - Custom Products: Consistent On-Time Delivery, On Quantity, On Quality, Solution Provider Competitors - Large Competitors With Exce

Slide 66: Broad Capabilities
sigma-aldrich.com Broad Capabilities 45% 17% 33% 5% SAFC Business Unit Overview

Slide 67: Product Consistency & Reliability Key To Growth
sigma-aldrich.com a a Product Consistency & Reliability Key To Growth - Quality and Low Cost Raw Material Sourcing - Solution Provider - Performance Reliability - High-Yielding Processes - Documentation - Process Development - Clinical Trial Support - Cell Line And Protein Characterization - Commerc

Slide 68: Product Consistency & Reliability Key To Growth
sigma-aldrich.com A A Product Consistency & Reliability Key To Growth - Quality and Ready To Use Without Refinement - Technical Knowledge And Application - Supplier Reputation - Knowledge Of Customer Process - Quality - Performance Reliability - Solution Provider - Multi-Compendium Products - Just-I

Slide 69: Exceed Customer Expectations
sigma-aldrich.com Exceed Customer Expectations SAFC Strategy Gain Market Share In High Growth Segments Through Exceeding Customer Expectations, Partnerships, Alliances, Or Acquisitions Revitalize Semi-Bulk Business – Launch Of Supply Solutions Expand On Customer Focused Technology Platforms Where Ap

Slide 70: Capabilities In All Phases Of Drug Development
sigma-aldrich.com SAFC JRH Biosciences Capabilities In All Phases Of Drug Development SAFC Pharma - Leverage Global, Robust Scale-up Processes - Increase Service Offering - Capture Late Phase Opportunities SAFC Biosciences - Penetrate Early Phase Clinical Pipeline - Capitalize On Manufacturing Knowl

Slide 71: Balance Volatility In Pharma Market
sigma-aldrich.com Balance Volatility In Pharma Market SAFC Hitech - Expand And Acquire Key Technologies - Diversify Customer Base - Quick Integration Of Epichem To Take Advantage Of Complete Offering SAFC Supply Solutions - Focused Sales and Marketing Approach - Exceed Customer Expectations on Servi

Slide 72: Unrivaled Scientific Knowledge
sigma-aldrich.com Unrivaled Scientific Knowledge Chemical/Technical Knowledge Commercial Experience Range Of Offering Innovation Global Reach Financial Stability SAFC Distinct Advantages Over Competitors

Slide 73: New Capabilities To Drive Future Growth
sigma-aldrich.com New Capabilities To Drive Future Growth SAFC 2006 Results 2006 Results: 12.7% Sales Growth (Currency Adjusted) (Adjusted For Currency And JRH Industrial Sales – 8.4%) Key Drivers - New Identity And Focus Provided Strong Double Digit Growth For Supply Solutions - 2006 Acquisitions E

Slide 74: Continue To Expand Capabilities
sigma-aldrich.com Continue To Expand Capabilities SAFC 2007 Goals and Initiatives Sales Increase Goal –10% - Including Epichem – 17% Major Initiatives Integrate New Acquisitions Expand Sales And Marketing Effort In Supply Solutions Improve Supply Chain To Exceed Customer Expectations Extend Capabili

Slide 75: Q&A - Business Units
sigma-aldrich.com Research Specialties 37% ($670M) Research Essentials 20% ($355M) SAFC 28% ($496M) Research Biotech 15% ($277M) Q&A - Business Units Sigma-Aldrich Business Units Business Units Customer Types Driving Forces Growth Goal Research Essentials Economic Buyers Relationship Selling 4% Rese

Slide 76: Committed to Accelerating our Customers' Success
We are Committed to Accelerating our Customers’ Success through Leadership in Life Science, High Technology and Service Enabling Science Globally Through Innovation

Slide 77: Five Key Initiatives
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 78: CAPLA: 25% Of Total Sales By 2010
sigma-aldrich.com CAPLA 25% Of Total Sales By 2010 CAPLA Markets 2006 Sales Asia Pacific 79% Canada & Latin America 21% CAPLA 18% USA & Europe 82% 13% 19% 9% 16% 14% 0% 5% 10% 15% 20%

Slide 79: New Initiatives / Improving Economy to Drive Growth
sigma-aldrich.com New Initiatives / Improving Economy to Drive Growth CAPLA Markets Japan >30 % Of CAPLA Sales 1 % Currency Adjusted Growth In 2006 Economy Beginning To Improve Efforts To Revitalize - Stay The Course: Sufficient Distribution Capacity; SAP Fully Implemented - Extend Direct Biotech Se

Slide 80: Emerging Markets - Key Factors
sigma-aldrich.com Opportunities Abound / Need To Participate Represent 30% Of World Economy, But 60% of 2005 GDP Growth All 32 Largest Emerging Economies Had Positive GDP Growth For 3 Consecutive Years Becoming More Integrated In World Economy Internet Globalizes Trade R&D Spend Much Smaller Emergin

Slide 81: Buumoesnuen, e @ @8 e
Buumoesnuen, e @ @8 e uopnqysia «6 @ OOOOH CO ee srpg@ @@C8eCOR EEE SIGMA-ALDRICH

Slide 82: Innovative Solutions For Customers
sigma-aldrich.com Innovative Solutions For Customers Execute Annual Country Planning Process - Alignment To Local Market Opportunities And Needs Regional OEM Of High Volume Essentials - Gain Market Share While Maintaining Margins - Leverage The Strength Of Our Brand Loyalty Supply Chain Solutions -

Slide 83: China & India High Growth Markets
sigma-aldrich.com China & India High Growth Markets Increase Presence In High Growth Countries % GPD Increase University students graduating in science and engineering, ‘000 90 95 2000 06* Source: IMF *Forecast Emerging Economies 1990-91 1992-04 India China European Union United States Japan Source:

Slide 84: Competitive Business Model In Emerging Markets
sigma-aldrich.com Competitive Business Model In Emerging Markets BRAZIL SAP Implementation (State-Of-The-Art Global System) Investment In Talent Inventory Build To Increase Service Levels To Customers CHINA Established Wholly Foreign Owned Enterprise (WFOE) Successfully Acquired And Integrated Beiji

Slide 85: Competitive Business Model In Emerging Markets
sigma-aldrich.com Competitive Business Model In Emerging Markets INDIA New 10-Acre, 172,000 ft Site Expanded Warehouse And Administration Facilities State-Of-The-Art Production Laboratories Contract Research, Custom Synthesis And Catalog Production Oligonucleotide Manufacturing And DNA Sequencing In

Slide 86: Continue Geographic Expansion
sigma-aldrich.com Continue Geographic Expansion Acquire Assets & Technology Successful Integration Of Beijing Superior In China Aggressive Review Of Additional Targets In Emerging Markets Increase Dedicated Staff To Focus On Acquisitions

Slide 87: Leverage Process Improvement
sigma-aldrich.com Leverage Process Improvement Optimize Supply Chain Global Sourcing Of Raw Materials Expand Current China And India Sourcing Team Leverage Know-How To Support Customers’ Needs Focus on Customer Service Enhancements Accelerate Collaboration Efforts With Contract Research Organization

Slide 88: Strengthen Market Leader Position In CAPLA
sigma-aldrich.com Strengthen Market Leader Position In CAPLA Strategy For Emerging Economies Accelerated Growth In Emerging Markets Localized Products And Services To Meet Customers’ Needs Increased Infrastructure To Support Local Growth Leverage Process Improvement To Drive Profitability Local Tale

Slide 89: Five Key Initiatives
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 90: A Leader In eCommerce
sigma-aldrich.com SIAL A Leader In eCommerce eCommerce Sales Integrated eCommerce Capabilities “e” Channels Now Represent 36% of Sigma-Aldrich Research Sales System-to-System (B2B) Sales Growing at 30% Year- Over-Year, and Represent 33% of Overall eCommerce International eCommerce Adoption is Accele

Slide 91: Most Visited Site In Science
sigma-aldrich.com SIAL - Most Visited Site In Science Strong Web Presence

Slide 92: A Fundamental Shift in Customer Behavior
sigma-aldrich.com Requires Strong Responses On Both The Customer-Facing And Internal Resource Allocation Fronts Traditional “Search Technology” is giving way to Web-based investigative methods A Fundamental Shift in Customer Behavior Channel Importance to Customer 10% 20% 30% 40% 50% '97 '01 '03 '04

Slide 93: Attracting Investigating Eyes To SIAL's Site
sigma-aldrich.com Attracting "Investigating Eyes" To SIAL's Site Customer-Centric Focus Search Engine Optimization Paid Search Affiliate Websites Website Visits 7,000,000 9,000,000 11,000,000 13,000,000 15,000,000 17,000,000 19,000,000

Slide 94: New Customer Behaviors Require New Skill Sets
sigma-aldrich.com New Customer Behaviors Require New Skill Sets Continued Innovation Required Search Technology - Custom Search Interfaces - Online Merchandising Interactive Content - New Content Product Configurators - Genosys Integration - Custom Packaging New Search Engine Sigma-Aldrich.Com Produ

Slide 95: Improving The Search Experience
sigma-aldrich.com A A A Improving The Search Experience Process: Search Refine Select Result Refinement Options GENE Search Changing the Assumptions Behind “Search”

Slide 96: Improving The Search Experience
sigma-aldrich.com A Improving The Search Experience GENE Search, continued…. Process: Search Refine Select Result Select Product

Slide 97: Broadened, Configurable Product Offering
sigma-aldrich.com Broadened, Configurable Product Offering Leveraging The Web To Add Value Cost Effective Medium To Expose Non-Catalog Products - 120,000 Product Library Of Rare Chemicals - 150,000 RNAi Clones In 3 Formats Effective Channel To Transition From Solely “Off The Shelf” Products To “On D

Slide 98: Enabling Mass Customization
sigma-aldrich.com Enabling Mass Customization Enabling Science Through Innovation Custom Product Configurator Custom and Standard Products in an on-line shopping cart Custom and Standard Products on ONE order in SAP ONE invoice to customer from Sigma-Aldrich

Slide 99: 2007 eCommerce Initiatives
sigma-aldrich.com Building On A History Of Innovation Connect Sigma-Aldrich With Customer Processes Using Traditional (EDI) And Newer (SOA) Methods Integrate Content, Search, Analytics And Usability Expand Content Management Strategy/Capabilities Increase Investment In Site Performance Deploy Websph

Slide 100: Five Key Initiatives
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 101: Every Improvement Requires Change
sigma-aldrich.com Every Improvement Requires Change Process Improvement Model AIM for improvement in key business processes MEASURES to determine if changes are improvements CHANGES to anything and everything can be tested for improvement

Slide 102: Reinvesting While Maintaining Margins
sigma-aldrich.com Reinvesting While Maintaining Margins Process Improvement Results 22.5 21.0 22.1 20.6 21.1 >$90M In Savings To Maintain Margins While Investing In Future Growth: - R&D - Valuable In Licenses - Collaborations - Sales / “Feet On Street” - Internet - $ Savings - Pre-Tax Margin

Slide 103: Producing Material Improvements to the Bottom Line
sigma-aldrich.com Producing Material Improvements to the Bottom Line Process Improvement Impact Examples – Cost Savings – Global Purchasing Efforts Saved More Than $8 Million Defect Reduction – Bellefonte Production Efforts Reduced Minor Defects In Filtration Columns Service Improvements – Multi-Sit

Slide 104: Testing & Learning Improve Quality & Drive Success
sigma-aldrich.com Testing & Learning Improve Quality & Drive Success Process Improvement Focus – More Of The Same($15M Savings Target) – PLUS: Generate Organic Top-line Growth - Application Of Improvement Methodologies To Achieve Sales Growth - New Initiatives In Key Areas To Drive Growth Including:

Slide 105: Testing & Learning Improve Quality & Drive Success
sigma-aldrich.com Testing & Learning Improve Quality & Drive Success Process Improvement Focus – Enhance the Supply Chain - Global Attention On Worldwide Supply Chain - Continue Driving SKU Rationalization And Product Consolidation Expand The Improvement Culture - Continued Development Of Growing Nu

Slide 106: Five Key Initiatives
sigma-aldrich.com Initiatives Set Actions For 2006 - Building For The Future 1. Align Structure With Customers And Markets 2. Expand In Faster Growing Geographic Markets 3. Build On Internet Superiority 4. Leverage Process Improvement For Excellent Investment Returns 5. Fill Growth Target Through Ac

Slide 107: Add To Growth/Maintain Returns
sigma-aldrich.com Add To Growth/Maintain Returns Acquisitions – General Criteria Acquisitions Must Create Shareholder Value Over Reasonable Planning Horizon: - Both Sales And Profit Growth > Long-Term Target (10%) - Meet Or Exceed Cost Of Capital (Roughly 15%) - Enhance Life Science/High Technology

Slide 108: Expansion Into New Markets To Fill Revenue Gap
sigma-aldrich.com Need Expansion Into New Markets To Fill Revenue Gap Acquisitions – Investment Opportunities New Market Opportunities In: - Regenerative Medicine (Stem Cells) - Electronics (Material Science) - Biomaterials (Material Science) - Contract Research Services - Analytical Services - Auto

Slide 109: Add Capabilities With Focus On Global Innovation
sigma-aldrich.com Add Capabilities With Focus On Global Innovation Acquisitions – Broad Strategy Primary Focus On Biotech, SAFC And Emerging Markets: - Biotech: “First To Market” Technologies For Development And Launch Of Innovative, Solution-Oriented Products - SAFC: - Capabilities To Retain/Enhanc

Slide 110: Screened Candidates Enter Internal Review Process
sigma-aldrich.com Screened Candidates Enter Internal Review Process Acquisitions - How We Source Candidates Third Parties • Venture Capital Firms Investment Bankers Direct Candidate Contact Internal Groups Business Development (Staff & Web Site) International Team Sales, R&D Marketing External Conta

Slide 111: Enough Targets To Achieve Objective
sigma-aldrich.com Enough Targets To Achieve Objective Acquisitions – Internal Review Horizons Screen - Revitalize - Growth Opportunities - Future Business Business Unit Analysis EMG Review Target Contact - Availability - Technical Details Due Diligence Formulate Proposal Board Approval (As Applicabl

Slide 112: Strategic Plan - Financial Objectives
sigma-aldrich.com Strategic Plan Financial Objectives Obtain Minimum 10% Top And Bottom Line Growth Maintain 20% Return On Equity Over Plan Period Maintain Effective Debt To Capital Ratio Reinvest Operations Cash In Sales And EPS Growth

Slide 113: Hold DSO/Improve MOH/Maintain Debt Ratio
sigma-aldrich.com Hold DSO/Improve MOH/Maintain Debt Ratio ($ In Millions) Balance Sheet ASSETS LIABILITIES AND EQUITY 12/31/06 12/31/05 12/31/06 12/31/05 Cash $ $ Receivables Short-term Debt $ $ Inventories Other Current Liabilities Other Current Assets Long-term Debt Property, Plant and Equipment

Slide 114: Active Working Capital Management
sigma-aldrich.com Provided $250 Million In Cash 2000 - 2005; Invested $42 Million In 2006 Active Working Capital Management 55% 49% 44% 41% 39% 40% 42% 0% 10% 20% 30% 40% 50% 60% Excluding JRH & Proligo 37% Percentage of Sales: (Accounts Receivable + Inventory – Accounts Payable) / Sales

Slide 115: Cash Flow - Sources and Uses
sigma-aldrich.com Operations Self-Funding Use Debt For Share Repurchase & Acquisitions Cash Flow - Sources and Uses Sources Operations Facility Sale Uses Dividends Capital Expenditures Acquisitions Share Repurchase (in 000’s)

Slide 116: Continue Modest Repurchase Program
sigma-aldrich.com Continue Modest Repurchase Program Repurchased 80.0 Million Shares 5.2m - 1999 45.9m - 2000 8.2m – 2001 5.2m – 2002 5.5m – 2.0m – 2004 4.0m – 2005 4.0m – Average Price: $19.19 Per Share (“All In”) Authorized Up To 10.0 Million More Shares Shares Outstanding 12/31/06 – 132.0 Million

Slide 117: Financially Strong - Expected Cash Flow
sigma-aldrich.com Financially Strong Operating Cash Flow $ 340-350 Cash Requirements - Capital Expenditures $ 80–85 - Dividends $ 60 - Acquisitions TBD - Share Repurchase TBD Expected Cash Flow – (In Millions)

Slide 118: Rewards Tied To Performance
sigma-aldrich.com Rewards Tied To Performance Performance Share Holding Opportunity Requirement Target Number Positions Included (Salary Multiple) (% Of Salary) Chairman 3X - President & CEO 3X 67% Business Unit Presidents, CAO/CFO, General Counsel) 2X 50% Key Management Group 1X 25% Senior Manageme

Slide 119: Employees Are Owners
sigma-aldrich.com Employees Are Owners Directors $ 341 $ 640 $ 1,865 5.5 Officers & Senior Managers 7,824 11,523 21,975 2.8 Directors/Managers * 1,724 10,542 12,636 7.3 $9,889 $22,705 $36,476 3.7 Times Current Total Shareholdings Current Requirement Requirement @ 12/31/06 Requirement * Began 1/1/06

Slide 120: Q&A: Initiatives & Finance
Enabling Science Globally Through Innovation Q&A: Initiatives & Finance

Slide 121: 2007 Goals
sigma-aldrich.com 2007 Goals Customer Centric - Increase Organic Sales >7% Growth In Faster Growth Economies >15% Internet & E-Commerce - Sales Results Through E-Channel 40% Process Improvement - Savings Target $15.0 Million Acquisitions - Screen & Complete $65 Million In Annual Revenue

Slide 122: 2007 Forecast
sigma-aldrich.com 2007 Forecast Sales - Organic Growth 7% - Acquisition Contribution – Epichem 2% - Currency (At 12/31/06 Rates) 2% EPS $2.15 – 2.25 + 5 – 10% ROE >20%

Slide 123: Summary
sigma-aldrich.com We Are Committed To Accelerating Our Customers' Success Through Leadership In Life Science, High Technology & Service Summary Strategy - Customer-Centric - Geographic Opportunities - Internet Superiority - Process Improvement - Acquisitions Competitive Advantages - Broad Product Li

Slide 124: Sigma-Aldrich Corporation
Sigma-Aldrich Corporation We are Committed to Accelerating our Customers’ Success through Leadership in Life Science, High Technology and Service
Source: SEC EDGAR · 8-K filed Mar 14, 2007
More decks from Sigma-Aldrich Corp
Merger or Acquisition (October 2014)40 slides · Oct 2, 2014
Merger or Acquisition (September 2014)11 slides · Sep 23, 2014
Merger or Acquisition (September 2014)55 slides · Sep 22, 2014
J.P. Morgan Healthcare Conference 201428 slides · Jan 13, 2014
Investor Presentation (September 2013)25 slides · Sep 11, 2013
Q2 2013 Earnings Presentation17 slides · Jul 23, 2013